Jci_page_head_homepage_01 Jci_page_head_homepage_02
Tae-Il Jeon, Bing Zhu, Jarrod L. Larson, Timothy F. Osborne
Published in Volume 118, Issue 11
J Clin Invest. 2008; 118(11):3693–3700 doi:10.1172/JCI36461
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
Identification of mT2R138 as novel SREBP-2 target gene.

SREBP-2 ChIP-chip analysis was performed in triplicate using 1.5 kb mouse whole genome promoter arrays from NimbleGen/Roche. (A) Representation of the hybridization of ChIP-enriched DNA to the genomic locus for T2R138 analyzed in the Signal Map software program. The top graph in light blue shows the log2 ratios of hybridization signals for tiled probes for SREBP-2 antibody–enriched ChIP DNA divided by nonenriched input DNA. The middle panel, with green symbols, shows a similar analysis when a control IgG fraction was used as antibody. The T2R138 gene coding sequence is indicated by the dark blue area in the bottom graph. chr6, chromosome 6. (B) Oligonucleotides were designed to amplify the binding region of the T2R138 promoter and used in a gene-specific qPCR to confirm the ChIP-chip result using equal amounts of DNA from the input, SREBP-2 antibody–enriched, or control IgG-enriched samples directly as indicated. Data are mean ± SEM; n = 3 for 3 separate experiments.